e) Drugs used in myasthenia gravis

Curriculum Unit: 2. Pharmacology of drugs acting on ANS:

This study module covers "Drugs used in myasthenia gravis", an integral component of the Year 2 Doctor of Pharmacy (Pharm.D) curriculum under Pharmacology-I (Pharmacology of drugs acting on ANS). Designed for clinical pharmacy scholars, the syllabus emphasizes mechanistic understanding, clinical relevance, and high-yield examination competencies.

Upon reviewing this syllabus topic, Pharm.D students are expected to demonstrate proficiency in:

• Understand the foundational etiology, classification, and clinical significance of Drugs used in myasthenia gravis.
• Analyze the underlying pathophysiology and disease manifestations relevant to Pharmacology of drugs acting on ANS.
• Evaluate evidence-based pharmacotherapeutic management, therapeutic drug choices, and dosage individualization.
• Identify critical patient monitoring parameters, adverse drug reactions (ADRs), and drug-drug interactions.

Standard literature and institutional sources for Pharmacology-I:

• [1]Pharmacy Council of India (PCI) Pharm.D Curriculum Syllabus Guidelines
• [2]Goodman & Gilman's: The Pharmacological Basis of Therapeutics (Brunton et al.)
• [3]Rang & Dale's Pharmacology (Humphrey P. Rang et al.)
• [4]Casarett & Doull's Toxicology: The Basic Science of Poisons